ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1706

Predictive Atherosclerotic Risk Factors At Inception in a Multicentre, Multinational Cohort

Murray B. Urowitz1, Dominique Ibanez1, D. D. Gladman2 and SLICC3, 1Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2Division of Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, 3Toronto Western Hospital, Division of Rheumatology, Toronto, ON, Canada

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Atherosclerosis and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment III: Cardiovascular

Session Type: Abstract Submissions (ACR)

Background/Purpose:   Patients with systemic lupus erythematosus (SLE) develop premature atherosclerosis (AS). This study examines predictive factors at inception for atherosclerotic vascular events (AVE) over a maximum 10 years of followup in a multicenter, international inception cohort.

Methods: An inception cohort of SLE patients from 31 centres from 12 countries has been assembled according to a standardized protocol between 2000 and 2012 to study risk factors for atherosclerosis. At yearly visits demographic and cardiovascular risk factors are collected and vascular events (VE) are described and attributed on a specialized form. Events recorded include myocardial infarction (MI), angina, congestive heart failure (CHF), intermittent claudication (PVD), stroke, and transient ischemic attack (TIA). Diagnosis of an event was confirmed using standard clinical criteria and diagnostic tests where appropriate. Attribution to AS was made by physicians on the basis of lupus disease being inactive at the time of the event, and/or the presence of typical AS changes on imaging or pathology and/or evidence of AS elsewhere.  Analysis was done using descriptive statistics and Cox proportional Hazard model.

Results: Of the inception cohort of 1844 SLE patients 93 had VE due to non-AS causes (e.g. active SLE or thrombosis) and 350 patients had only enrolment data leaving 1401 patients.  31 patients had 41subsequent AVE after enrollment.  The mean time to AVE or last clinic followup was 5 years.  distribution Patients’ race/ethnicity distribution was as follows: 51% Caucasian, 16% Black, 17% Asian 12% Hispanic 4% other. At enrollment risk factors for AS are shown in the table 1.

 

Patients without AVE  no=1370

Patients with AVE n=31

P value

Age

34.6±13.1

56.0±13.8

<0.0001

Sex, %

90.6

58.1

<0.0001

Diabetes, %

3.2

10.7

0.06

Framingham risk Score Mod/High, %

1.5

25.0

0.001

Smoker ever, %

35.7

61.3

0.004

Obese, %

29.3

53.6

0.01

Hypertension, %

32.6

60.0

0.003

Hypercholesterolemia, %

34.7

50.0

0.12

Increased LDL*, %

33.3

33.3

1.00

Increased Creatinine, %

23.5

47.8

0.01

*LDL=low density lipoprotein

Table 2. Time to Event Analysis 1 risk factor at a time

 

Hazard Ratio

95% CI

p value

One risk factor at a time

Age

1.09

1.07, 1.12

<0.0001

Caucasian

3.39

1.46, 7.87

0.005

Male

6.30

3.09, 12.87

<0.0001

FRS  Mod/High

13.15

3.99, 43.22

0.0001

Smoker ever

2.95

1.43, 6.09

0.003

Obesity

2.92

1.39, 6.14

0.005

Hypertension

3.10

1.49, 6,43

0.002

Hypercholesterolemia

1.85

0.90, 3.77

0.09

Stepwise regression with all above variables

Age

1.09

1.06, 1.11

<0.0001

Male

4.07

1.84, 9,04

0.0006

*FRS=Framingham Risk Score

Conclusion: Only age and male sex remain significant risk factors for AVE in a multivariate analysis of a multicentre inception cohort followed for a mean of 5 years.


Disclosure:

M. B. Urowitz,
None;

D. Ibanez,
None;

D. D. Gladman,
None;

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predictive-atherosclerotic-risk-factors-at-inception-in-a-multicentre-multinational-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology